ARCHIVES

NSABP Disputed NCI Cost Estimate For P-4 Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 20 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

U.S., France Offer Carcinogenesis Program

February 13, 1981

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014